SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-008198
Filing Date
2024-02-15
Accepted
2024-02-15 16:57:39
Documents
15
Period of Report
2024-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20021804_8k.htm   iXBRL 8-K 39256
  Complete submission text file 0001140361-24-008198.txt   226154

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmy-20240213.xsd EX-101.SCH 4697
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20240213_def.xml EX-101.DEF 18375
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20240213_lab.xml EX-101.LAB 28470
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20240213_pre.xml EX-101.PRE 20674
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20021804_8k_htm.xml XML 8285
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 24644613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)